Physician profile
Catherine Gu
NPI 1013478833
$2,687.18
in general payments reported to CMS, 2019-2025
9 companies · $1,261 in 2025
The $1,261 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $543 · 2024: $883 · 2025: $1,261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,143.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,232.97 | 2024-2025 | Ams 700, Ams 700 Cxr Rte Kit |
| Coloplast Corp | $533.93 | 2022-2025 | |
| Endo USA, INC. | $386.94 | 2024-2025 | Xiaflex, Aveed, Edex |
| Antares Pharma, INC. | $290.23 | 2022-2025 | Xyosted |
| Olympus America INC. | $147.59 | 2022 | |
| Avation Medical, INC. | $29.26 | 2025 | Vivally System |
| Janssen Biotech, INC. | $26.38 | 2025 | Erleada |
| Sumitomo Pharma America, INC. | $20.12 | 2025 | Gemtesa |
| Ferring Pharmaceuticals INC. | $19.76 | 2025 | Adstiladrin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Gu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.